Back to search
FDAFDA · Food and drugs·Recall number D-1512-2019

Temozolomide Capsules, 180 mg, packaged in a) 5-count bottle (NDC 67877-541-07), b) 14-count bottle (NDC 67877-541-14), Rx only, Manufactured by: Deva Holding A.S., 1 Merkez Mahallesi, Istanbul, Turkey 34303, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054.

Published July 31, 2019 · Recall initiated: July 16, 2019

Summary

FDA records drug Class II recall D-1512-2019, published July 31, 2019 and initiated July 16, 2019. Recalling firm: Deva Holding AS - Cerkezkoy Subesi; Status: Terminated; Reported quantity: a) 5052 bottles; b) 3816 bottles; Lot: Lot #: a) A061858, A061857, A061856, A061860, A061859, Exp 07/31/2019; A069401, A069402, Exp 05/31/2020; A071978, Exp 09/30/2020; A076736, A076735, Exp 04/30/2021; b) A062031. A062015, A062014, A062050, A062038, Exp 07/31/2019; A069521, A069470, Exp 05/31/2020; A071979, A072014, A072013, Exp 09/30/2020; A076739, A076738, A076737, Exp 04/30/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.

What to do

Voluntary: Firm initiated · E-Mail

Get an email if TEMOZOLOMIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
TEMOZOLOMIDE
Manufacturer
Deva Holding AS - Cerkezkoy Subesi
Distributor
Nationwide in the USA.
Lot
Lot #: a) A061858, A061857, A061856, A061860, A061859, Exp 07/31/2019; A069401, A069402, Exp 05/31/2020; A071978, Exp 09/30/2020; A076736, A076735, Exp 04/30/2021; b) A062031. A062015, A062014, A062050, A062038, Exp 07/31/2019; A069521, A069470, Exp 05/31/2020; A071979, A072014, A072013, Exp 09/30/2020; A076739, A076738, A076737, Exp 04/30/2021
Risk classification
Class II
Area (FDA)
drug
Country
Turkey

Related recalls

Questions about this recall

Was Temozolomide Capsules, 180 mg, packaged in a) 5-count bottle (NDC 67877-541-07), b) 14-count bottle (NDC 67877-541-14), Rx only, Manufactured by: Deva Holding A.S., 1 Merkez Mahallesi, Istanbul, Turkey 34303, Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054. recalled?

Yes. FDA published recall D-1512-2019 on July 31, 2019. Reported hazard: CGMP Deviations: product was manufactured that did not prevent possible cross contamination with beta lactam products.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: TEMOZOLOMIDE.